Curcumin, a member of curcuminoids, is a bioactive compound isolated from the rhizome of turmeric. Curcuminoids are used as a traditional Asian medicine and spice because of their various biological activities, 1, 2) such as anti-inflammatory, antioxidant, anticarcinogenic, and antitumor. Recent studies have revealed that curcumin possess a potential role in treating Alzheimer's disease and hepatoprotective activity in liver injury. [3] [4] [5] [6] We recently elucidated the curcuminoid biosynthetic pathway in the rhizome of turmeric. 7) Curcuminoids are synthesized via sequential reactions catalyzed by two distinct type III polyketide synthases (PKSs), named diketide-CoA synthase (DCS) and curcumin synthase (CURS). DCS catalyzes the condensation of malonyl-CoA onto feruloyl-CoA to give feruloyldiketide-CoA. CURS catalyzes the formation of curcuminoids from feruloyl-CoA and the feruloyldiketide-CoA synthesized by DCS. 7) In addition to the DCS/CURS biosynthetic system in the rhizome of turmeric, we have also discovered and characterized another type III PKS, curcuminoid synthase (CUS), in the rice plant, Oryza sativa. 8) CUS catalyzes curcuminoid synthesis as follows: first, pcoumaroyl-CoA and malonyl-CoA are condensed to form a diketide-CoA intermediate. Condensation of the synthesized diketide-CoA and another molecule of pcoumaroyl-CoA results in the synthesis of bisdemethoxycurcumin (2c). CUS itself catalyzes both steps that are catalyzed by DCS and CURS, and thus the CUS system is simpler than the DCS/CURS system. In this respect, CUS is a better enzyme than DCS/CURS enzymes for the purpose of metabolic engineering of curcuminoids in microorganisms.
We have demonstrated microbial production of curcuminoids by reconstructing an artificial curcuminoid biosynthesis pathway in Escherichia coli. 9) This pathway included a phenylalanine ammonia-lyase (PAL) from the yeast Rhodotorula rubra, 4-coumarate:CoA ligase (4CL) from Lithospermum erythrorhizon, and CUS from the rice plant. The acetyl-CoA carboxylase (ACC) from the Gram-positive bacterium Corynebacterium glutamicum was also included to increase the intracellular pool of malonyl-CoA. Cultivation of E. coli cells in the presence of tyrosine or phenylalanine, or both, led to the production of bisdemethoxycurcumin (2c), dicinnamoylmethane (1c), and cinnamoyl-p-coumaroylmethane. Another E. coli system carrying 4CL on plasmid pCDF-LE4CL-1, CUS on pET-CUS, and ACC on pRSF-ACC was used in the production of curcuminoids, and exogenous supplementation of cinnamic acid (1a), p-coumaric acid (2a), and ferulic acid (6a) led to the formation of dicinnamoylmethane (1c), bisdemethoxycurcumin (2c), and curcumin (6c) respectively.
9)
The three compatible plasmids, containing the three genes under the control of the isopropyl--D-thiogalactopyranoside (IPTG)-inducible T7 promoter, were simultaneously maintained in the same E. coli cell. 9) Precursor-directed biosynthesis is a useful strategy to produce structurally diverse compounds in organisms. 10) This strategy is based on the broad substrate tolerance of the enzymes involved in the biosynthesis of natural products. If the unnatural substrates or intermediates are accepted by the enzyme and/or the entire biosynthetic pathway, the unnatural moiety of the substrates or intermediates is inherited by the final products. This strategy has been employed successfully in the production of novel polyketides by a type I PKS mutant that was blocked in the early stage of biosynthesis of a natural product. For example, Jacobsen et al. 11) produced erythromycin analogs by feeding intermediate analogs to Streptomyces that possessed a mutant type I PKS lacking a module to load substrates onto the enzyme. We have developed a precursor-directed biosynthesis system to produce unnatural flavonoids and stilbenoids by type III PKS. We supplied various carboxylic acids to E. coli cells carrying 4CL and either chalcone synthase or stilbene synthase, and successfully produced the corresponding unnatural compounds. [12] [13] [14] In this paper, we describe the precursor-directed biosynthesis of curcumin analogs exploiting E. coli y To whom correspondence should be addressed. Tel: +81-3-5841-5124; Fax: +81-3-5841-8021; E-mail: anuf@mail.ecc.u-tokyo.ac.jp Abbreviations: CoA, coenzyme A; CURS, curcumin synthase; CUS, curcuminoid synthase; DCS, diketide-CoA synthase; HPLC, high-performance liquid chromatography; HR-MS, high resolution mass spectrometry; LC-APCIMS, liquid chromatography-atmospheric pressure chemical ionization mass spectrometry; MS/MS, tandem mass spectrometry; NMR, nuclear magnetic resonance; PKS, polyketide synthase carrying an artificially assembled pathway for curcuminoid biosynthesis. By feeding various analogs of pcoumaric acid to E. coli harboring CUS, ACC, and 4CL, we succeeded in the production of 15 curcuminoids. In addition, we showed that asymmetric curcuminoids can be produced by adding two different carboxylic acids simultaneously.
Materials and Methods
Materials. E. coli strain BLR (DE3) was purchased from Takara Biochemicals (Shiga, Japan). pCDF-LE4CL-1, pRSF-ACC, and pET-CUS were described previously.
9)
Production of curcuminoids by E. coli. Ampicillin (100 mg/ml), kanamycin (50 mg/ml), and streptomycin (50 mg/ml) were used when necessary. Recombinant E. coli BLR (DE3) cells were precultured overnight at 37 C in 2 ml of Luria-Bertani (LB) medium. The preculture was transferred into 100 ml of LB medium and cultured at 26 C until the optical density at 600 nm (OD 600 ) reached 0.6. Isopropyl--D-thiogalactopyranoside (IPTG) was then added at a final concentration of 1 mM, and the culture was continued for 5 h. The cells were harvested by centrifugation, and then the cells (0.5 g of wet weight) were suspended in 20 ml of M9 medium. To the cell suspension (25 g/l of wet weight) in M9 medium, 1 mM each of carboxylic acids, 40 g/l of glucose, 25 g/l of CaCO 3 , appropriate antibiotics, and 1 mM IPTG were added, and the culture was incubated at 26
C for 60 h. CaCO 3 was added to maintain the pH of the culture. After incubation, 2 ml of the culture broth was harvested and adjusted to pH 3.0 with 6 M HCl. After extraction with an equal volume of ethylacetate, the materials were concentrated by evaporation and dissolved in 100 ml of dimethyl sulfoxide for high-performance liquid chromatography (HPLC) and liquid chromatography-atmospheric pressure chemical ionization tandem mass spectrometry (LC-APCIMS/MS) analysis. LC-APCIMS in positive mode was performed on an esquire High-capacity trap plus (Bruker Daltonics, Bremen, Germany) equipped with a PEGASIL-B C 4 column (4:6 Â 250 mm; Senshu Scientific, Tokyo, Japan), and the sample was eluted with a gradient of acetonitrile in water (both containing 0.1% acetic acid) at a flow rate of 1 ml/min. The conditions of the gradient were 10-100% CH 3 CN for 45 min. UV spectra were detected on an agilent 1100 series UV detector (Agilent Technologies, California, USA). HPLC with a Senshu PEGASIL-B C 4 reversed-phase HPLC column (4:6 Â 250 mm) was carried out on a Hitachi LaChrom ELITE system (Hitachi HighTechnologies, Tokyo, Japan), and the sample was eluted with a linear acetonitrile gradient (10-100% over 45 min) in water containing 0.1% trifluoroacetic acid at a flow rate of 1.0 ml/min. UV spectra were detected on a Hitachi L-2450 diode array detector.
Structural elucidation of curcuminoids. Curcuminoids were identified by nuclear magnetic resonance (NMR) spectroscopic studies and LC-APCIMS analysis. Each of the curcuminoids was prepared from a 200 ml-scale M9 culture as described above and purified by reversedphase preparative HPLC. Spectroscopic data for the curcuminoids were as follows: 
Results and Discussion
In the present study, we attempted to produce unnatural curcuminoids by supplying unnatural carboxylate precursors to E. coli cells harboring pCDF-LE4CL-1, pET-CUS, and pRSF-ACC. The structures of the plasmids were described previously. 9) In this system, exogenously supplemented carboxylic acids are activated by the action of 4CL into the corresponding CoA esters, which are then condensed to form the corresponding curcuminoids by the action of CUS (Fig. 1) . As representatives of the unnatural precursors, we first chose p-fluorocinnamic acid (7a) and 3,4-methylenedioxycinnamic acid (14a CoA esters 
C for 60 h in M9 medium, which contains antibiotics to maintain the plasmids and IPTG to induce the T7 promoter. The details of the cultural conditions are described in ''Materials and Methods'' above. The reactions resulted in the production of compounds that were predicted to be curcuminoids by LC-APCIMS/MS analysis (Fig. 2B  and D) . These compounds (7c and 14c) were extracted from the recombinant E. coli cells and broth with ethyl acetate, and were purified by HPLC. The 1 H NMR and high resolution mass spectrometry (HR-MS) data, listed in ''Materials and Methods,'' clearly showed that these two compounds were curcuminoids, di-4-fluorocinnamoylmethane (7c) and di-3,4-methylenedioxycinnamoylmethane (14c).
In addition to the two carboxylic acids (7a and 14a), 13 p-coumaric acid analogs were used in the production of natural and unnatural curcuminoids (Fig. 1) . These analogs were also utilized as precursors of the curcuminoid biosynthetic pathway reconstituted in E. coli to produce the corresponding curcuminoids, as revealed by HPLC, LC-APCIMS/MS, 1 H NMR and HR-MS analysis. In total, we were able to produce 15 curcuminoids (Fig. 1) . Nine of these compounds are not found in nature. We measured the yields of 7c by means of the chromatographic peak area of the curcuminoid as a representative. The yield of 7c was 109 AE 8 mg/l, and this rate was comparable to those (about 100 mg/l culture) of natural curcuminoids reported previously.
9)
The yields of the other curcuminoids were also about 100 mg/l (data not shown), except for 5c and 13c, which were produced in smaller amounts. The difference in yield was probably due to the substrate preferences of 4CL and CUS. Trace amounts of triketide pyrones, which are byproducts of the CUS reaction, were simultaneously produced in all the reactions (data not shown).
Curcuminoids were synthesized from two carboxylate precursors and an acetate, which was derived from Absorbance at 420 nm (Au) A, Schematic diagram of the production of asymmetric curcuminoids. B, Recombinant E. coli cells produce chimeric curcuminoid 16c from 6a and 10a. C, Chimeric curcuminoid 17c from 1a and 15a.
malonyl-CoA. As described above, we have demonstrated the production of symmetric curcuminoids from a sole carboxylate precursor. We expected that if two different precursors were added to recombinant E. coli, CUS would synthesize asymmetric curcuminoids that possess a chimeric structure derived from both of the carboxylates (Fig. 3A) . We chose two pairs of carboxylates as representatives to produce asymmetric curcuminoids (Fig. 3B, C) . The reaction with the pair, ferulic acid (6a) and p-chlorocinnamic acid (10a), yielded 16c (Fig. 4B) , as revealed by HPLC, LC-APCIMS/MS, 1 H NMR and HR-MS analysis. Similarly, the reaction with another pair, cinnamic acid (1a) and 2-indoleacrylic acid (15a), yielded 17c (Fig. 4D) . The yields of 16c and 17c were 8:4 AE 1:1 and 26 AE 3 mg/l respectively. In both cases, symmetric curcuminoids (6c, 10c, 1c, and 15c) were also produced. Compounds 10c, 1c, and 15c were detectable only by LC-APCIMS analysis (data not shown). The production ratios of the asymmetric over the symmetric compounds were different among the supplied precursors. When ferulic acid (6a) and p-chlorocinnamic acid (10a) were supplied, the symmetric curcuminoid (6c) was more abundant than the asymmetric one (16c) (Fig. 4B) . In contrast, when cinnamic acid (1a) and 2-indoleacrylic acid (15a) were supplied, the asymmetric curcuminoid (17c) was the major product (Fig. 4D) . The difference in the production ratio was presumably due to the substrate specificities of the 4CL and CUS enzymes.
This report describes the microbial production of unnatural curcuminoids by means of precursor-directed biosynthesis. The addition of various carboxylic acids to recombinant E. coli cells carrying an artificially assembled pathway for curcuminoid synthesis led to the successful production of curcuminoids with diverse structures. Furthermore, we have developed a system to generate asymmetric curcuminoids by adding two different precursors simultaneously. Theoretically, x C 2 kinds of asymmetric curcuminoids can be produced from X kinds of precursors. Therefore, if the availability of the analogs of p-coumaric acid increases, the diversity of unnatural curcuminoids should drastically increase. Modifications of the culture conditions and the substrate specificities of CUS and 4CL should be useful for improvement of the yield of unnatural curcuminoids. Because curcuminoids are focused on as potential pharmaceutical resources, the present strategy of producing unnatural curcuminoids might provide novel drug candidates. Recombinant E. coli cells were cultivated in the presence of two different carboxylic acids. When supplemented with 6a and 10a, E. coli carrying 4CL, ACC, and CUS produced 16c (B), whereas E. coli harboring only 4CL and ACC did not produce any products (A). The E. coli cells supplemented with 1a and 15a produced 17c (D), whereas E. coli carrying only 4CL and ACC did not produce any products (C).
